Bragar Eagel & Squire, P.C. Is Investigating Everbridge, Aligos, Labcorp., and SunPower and Encourages Investors to Contact the Firm
February 11, 2022 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Feb. 11, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Everbridge, Inc. (NASDAQ:...
Bragar Eagel & Squire, P.C. Is Investigating Laboratory Corp., Hollysys Automation, and Cronos Group and Encourages Investors to Contact the Firm
February 06, 2022 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Feb. 06, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Laboratory Corporation of...
Bragar Eagel & Squire, P.C. Is Investigating Aligos, SunPower, and Labcorp and Encourages Investors to Contact the Firm
January 26, 2022 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Aligos Therapeutics, Inc....
Interpace Announces Extension of LabCorp Agreement
February 24, 2020 06:55 ET
|
Interpace Biosciences, Inc.
ThyGeNEXT and ThyraMIR Collaboration Extended for Another Two Years PARSIPPANY, NJ, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (NASDAQ: IDXG) announced today that its...
OmniSeq and LabCorp Extend Exclusive Distribution Pact and Complete Follow-On Investment Agreement
April 23, 2019 08:00 ET
|
OmniSeq
BUFFALO, N.Y., April 23, 2019 (GLOBE NEWSWIRE) -- OmniSeq®, a CAP-accredited, molecular diagnostics spin-out of Roswell Park Comprehensive Cancer Center, and LabCorp® (NYSE: LH), a leading global...
Interpace Diagnostics Announces Further Expansion of Thyroid Business
January 22, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
Interpace Only Provider Validated to Offer MDx Tests on Three Distinct Platforms PARSIPPANY, NJ, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (IDXG) announced today that it...
Laboratory Economics Issues Research Report on U.S. Clinical Laboratory Testing Market
August 14, 2018 08:00 ET
|
Laboratory Economics
POUGHKEEPSIE, N.Y., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Get ready for some major market challenges ahead in the $97 billion U.S. lab industry according to a new research report, "The U.S. Clinical...
OmniSeq, Inc. to Participate in the NCI-MATCH Clinical Trial
July 31, 2018 16:05 ET
|
OmniSeq
BUFFALO, N.Y., July 31, 2018 (GLOBE NEWSWIRE) -- OmniSeq, Inc.® a leading innovator in molecular science, today announced it is participating as a CLIA-certified/accredited laboratory for the...
OmniSeq and LabCorp Launch OmniSeq Advance℠ Assay
June 01, 2018 16:11 ET
|
OmniSeq
CHICAGO, June 01, 2018 (GLOBE NEWSWIRE) -- ASCO – OmniSeq®, a CAP-accredited, molecular diagnostics subsidiary of the Roswell Park Comprehensive Cancer Center, and LabCorp® (NYSE:LH), a leading...
Hitachi High-Tech Participates in OmniSeq Series B and Secures Japanese Distribution Rights
April 12, 2018 09:00 ET
|
OmniSeq
BUFFALO, N.Y., April 12, 2018 (GLOBE NEWSWIRE) -- OmniSeq®, a molecular diagnostics subsidiary of the Roswell Park Comprehensive Cancer Center, announced today Hitachi High-Technologies Corporation...